[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
SRPT discussions are trending with high engagement, suggesting positive financial outlook. Revenue generation strategies are also being promoted.
A topic related to financial metrics, possibly a company or a financial goal.
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXX
1 Month: XXXXXX +72%
1-Year High: XXXXX on 2025-07-12
1-Year Low: X on 2025-06-28
Social Network | X | YouTube |
---|---|---|
Engagements | XXX | X |
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: X -XX%
1 Month: XX +300%
1-Year High: X on 2025-07-04
1-Year Low: X on 2025-05-15
Social Network | X | YouTube |
---|---|---|
Mentions | X | X |
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $500myr in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: X
1 Week: X -XX%
1 Month: XX +433%
1-Year High: X on 2025-07-04
1-Year Low: X on 2025-05-15
Top assets mentioned In the posts about $500myr in the last XX hours
Sarepta Therapeutics, Inc. (SRPT) Sarepta Therapeutics, Inc. (SRPT)
Top topics mentioned In the posts about $500myr in the last XX hours
$srpt, sarepta therapeutics inc, stocks healthcare
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$SRPT if they only need $500m/yr of elevidys revenue to stay profitable then they will have extremely strong FCF I don't see a world where they only dose XX people per quarter in 26/27"
@BalaBioResearch on X 2025-07-16 21:07:10 UTC XX followers, 1047 engagements
"Steal The System We Implement For Our Elite Clients (Over $500M/Yr In Revenue)"
@coledavidtaylor on YouTube 2025-07-15 18:50:07 UTC XXX followers, XX engagements